INS and diabetes mellitus: Elevated levels of PP secretion observed in diabetics (Floyd et al., 1976) is hypothesized to be a compensatory mechanism to increase insulin release and improve glycemic control (Floyd et al., 1976; Kim et al., 2014); this may also enhance brain insulin signaling and glucose metabolism, and thereby reduce MCI risk (Roberts et al., 2013).